Claritev (CTEV) Morgan Stanley 24th Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley 24th Annual Global Healthcare Conference summary
22 Sep, 2026Industry trends and market environment
Healthcare costs remain elevated, with employers facing ongoing pressure and care shifting to new venues such as urgent care, ASCs, and at-home services.
Regulatory complexity and lack of pricing transparency persist, driving demand for solutions that address fraud, waste, and abuse.
Self-funded plans and stable unemployment are expected to keep utilization steady, while new care models and venues expand.
The company serves 50 million members, focusing on affordability, transparency, and access across a large provider network.
Strategic vision and transformation
Vision 2030 guides a multi-year transformation, with 2024 as the foundation year, 2025 as the turn (new markets), and 2026–2027 as aggressive growth and modernization.
Five consecutive quarters of year-over-year growth mark a turnaround after years of revenue decline.
Technology modernization, including a data mesh and AI integration, underpins the strategy.
AI is actively used, with over 30 agents deployed and a focus on leveraging proprietary data for competitive advantage.
Financial performance and growth drivers
Bookings reached $74 million in Q2, tracking ahead of the $100 million annual target, driven by new markets and expanded go-to-market structure.
About one-third of bookings now come from the TPA segment, a new focus area, with diversification reducing reliance on top clients.
75% of bookings are from the existing install base, but net new logos are increasing, with 30 added in the past 18 months.
Revenue is expected to return to $1 billion this year for the first time in four years.
Latest events from Claritev
- Transformation drives growth, margin strength, and leadership in healthcare claims innovation.CTEV
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 revenue up 6.6%, guidance raised, but legal and IT risks remain.CTEV
Q2 2026 - Record bookings, tech investment, and strong client ties drive ambitious 2030 growth targets.CTEV
Bank of America Global Healthcare Conference 2026 - Q1 2026 revenue grew 5.8% to $244.7M, with margin gains but continued net losses.CTEV
Q1 2026 - All proposals, including director elections and plan amendments, were approved without contest.CTEV
AGM 2026 - Transformation and innovation drive growth, profitability, and expanded market reach.CTEV
44th Annual J.P. Morgan Healthcare Conference - Six new market segments, tech innovation, and a $200M pipeline drive growth into 2026.CTEV
BofA Securities Leveraged Finance Conference 2025 - Q1 2025 revenue was $231.3M, net loss narrowed, and transformation advanced.CTEV
Q1 2025 - 2024 net loss surged on a $1.49B impairment as transformation and rebranding drive long-term optimism.CTEV
Q4 2024